Half-year report · HY
4937.TEDINET S100Y3R1
Period2025-10-01 → 2026-03-31
Filed2026-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.1bn | 2025-10-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥2.0bn | 2024-10-01 → 2025-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥835m | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Operating income | ¥138m | 2025-10-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | −¥52m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥135m | 2025-10-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥152m | 2024-10-01 → 2025-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥55m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥135m | 2025-10-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥55m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥136m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥44m | 2024-10-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥59m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥136m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | −¥59m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥3.4bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥3.2bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥3.0bn | at 2025-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.2bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.1bn | at 2025-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥2.2bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.1bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥2.1bn | at 2025-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.3bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2024-09-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥163m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥136m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥10m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥4m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥189m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥88m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥92m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥150m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥123m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥38.63 | 2025-10-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.32 | 2024-10-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-16.36 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥38.41 | 2025-10-01 → 2026-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥12.24 | 2024-10-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 65.6% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.1% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-10-01 → 2026-03-31 | ¥126m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-10-01 → 2026-03-31 | ¥126m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-10-01 → 2026-03-31 | ¥95m |
| Reconciling Itemsreconciling | revenue | 2025-10-01 → 2026-03-31 | −¥539,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2025-10-01 → 2026-03-31 | −¥539,000 |
| Reconciling Itemsreconciling | segment profit | 2025-10-01 → 2026-03-31 | −¥208m |
| Direct To Consumer Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥376m |
| Direct To Consumer Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥376m |
| Direct To Consumer Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥163m |
| Medical Supportreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥632m |
| Medical Supportreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥632m |
| Medical Supportreportable segment | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥539,000 |
| Medical Supportreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥88m |
| —segment total | revenue | 2025-10-01 → 2026-03-31 | ¥1.0bn |
| —segment total | revenue external | 2025-10-01 → 2026-03-31 | ¥1.0bn |
| —segment total | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥539,000 |
| —segment total | segment profit | 2025-10-01 → 2026-03-31 | ¥251m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-10-01 → 2026-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-10-01 → 2026-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥539,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-10-01 → 2026-03-31 | ¥346m |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥187m |
| Direct To Consumer Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥503m |
| Direct To Consumer Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥503m |
| Direct To Consumer Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥144m |
| Medical Supportreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥332m |
| Medical Supportreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥332m |
| Medical Supportreportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥9m |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥835m |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥835m |
| —segment total | segment profit | 2024-10-01 → 2025-03-31 | ¥135m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-10-01 → 2025-03-31 | ¥835m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-10-01 → 2025-03-31 | ¥835m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-10-01 → 2025-03-31 | ¥135m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 455
| Item | Context | Value | Unit |
|---|---|---|---|
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | InterimInstant_No1MajorShareholdersMember | Original text (Japanese)ＳＢＣメディカルグループ株式会社 | |
| Address major shareholders | InterimInstant_No1MajorShareholdersMember | Original text (Japanese)神奈川県横浜市戸塚区上倉田町908番地 | |
| Name major shareholders | InterimInstant_No2MajorShareholdersMember | Original text (Japanese)井上 裕基 | |
| Address major shareholders | InterimInstant_No2MajorShareholdersMember | Original text (Japanese)東京都港区 | |
| Name major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)株式会社Ｍ＆Ｍ | |
| Address major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)東京都港区浜松町２丁目２－15 浜松町ダイヤビル２F | |
| Name major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)株式会社ＭＣ | |
| Address major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)東京都港区西新橋３丁目24－10 | |
| Name major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)前田 敏彦 | |
| Address major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)東京都渋谷区 | |
| Name major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)佐俣 文平 | |
| Address major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)神奈川県藤沢市 | |
| Name major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)株式会社ＳＢＩ証券 | |
| Address major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)東京都港区六本木１丁目６番１号 | |
| Name major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)ＭＳＩＰ ＣＬＩＥＮＴ ＳＥＣＵＲＩＴＩＥＳ （常任代理人 モルガン・スタンレーＭＵＦＧ証券株式会社） | |
| Address major shareholders | InterimInstant_No8MajorShareholdersMember | Text · Plus | |
| Name major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)株式会社丸喜堂 | |
| Address major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)東京都新宿区新宿６丁目２－４ | |
| Name major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)大和証券株式会社 | |
| Address major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内１丁目９番１号 | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式であります。なお、単元株式数は100株であります。 | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)株式会社Waqoo | |
| Address of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)東京都世田谷区上馬２丁目14番１号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated financial statements financial information | InterimDuration | Text · Plus | |
| Note on independent audit financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated balance sheet (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of comprehensive income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of cash flows (text) | InterimDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | InterimDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1InterimDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | InterimDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | InterimDuration | Text · Plus | |
| Notes segment information etc type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | InterimDuration | Text · Plus | |
| Disclosure of changes etc in reportable segments (text) | InterimDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |